AEZS Aeterna Zentaris Inc.

4.13
+0.1  (+2%)
Previous Close 4.03
Open 4.06
Price To Book 9.04
Market Cap 67900339
Shares 16,440,760
Volume 189,172
Short Ratio
Av. Daily Volume 350,594

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued November 2014. Approval announced following resubmission December 20, 2017.
Macimorelin Acetate - Macrilen
Adult Growth Deficiency
Phase 3 trial did not meet primary endpoint - May 1, 2017.
Zoptrex
Endometrial cancer